SPONSORED CONTENT
TIP: Entities using third-party administrators (TPAs) should understand system functionality and strengthen oversight with regular audits to reduce compliance risks.
More From Our Sponsor:
Apexus
Apexus
SPONSORED CONTENT
TIP: Master manufacturer refund challenges with actionable steps.
Managing manufacturer refunds in the 340B Drug Pricing Program
SPONSORED CONTENT
Join Apexus at an upcoming webinar, Resolving 340B Noncompliance: From Reversals to Refunds, on Wednesday, January 15. This webinar will review different options available for resolving ineligible 340B purchases, including claim reversals, manufacturer repayments, and other options.
Our expert speakers will
…
SPONSORED CONTENT
Note: The Advanced 340B Operations Certificate Program is a separate Apexus offering that is not a part of the 340B Prime Vendor Program or otherwise associated with the Prime Vendor Agreement between HRSA and Apexus.
The 340B drug pricing
…
SPONSORED CONTENT
The Health Resources and Services Administration (HRSA) conducts randomized audits to assess compliance with the 340B drug pricing program, a federal initiative aimed at providing discounted medications to eligible entities. With more than 13,100 parent entities participating in 340B, this increased
…
SPONSORED CONTENT
TIP: Keep the complicated operations of your 340B program compliant with the expertise of the Apexus Advanced 340B Operations Certificate Program.
×
*Sign up for news summaries and alerts from 340B Report